Literature DB >> 14702268

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.

Zubin Bhagwagar1, Philip J Cowen, Guy M Goodwin, Catherine J Harmer.   

Abstract

OBJECTIVE: The present study aimed to 1) assess facial expression recognition in subjects with a previous history of major depressive disorder relative to subjects with no history of depression and 2) characterize the effects of acute citalopram infusion on recognition performance for both groups.
METHOD: Unmedicated euthymic women with a history of major depression and matched comparison subjects with no history of depression were given a facial expression recognition task following intravenous infusion of saline or citalopram (10 mg) in a double-blind, between-group design.
RESULTS: Following saline infusion, subjects with a previous history of depression showed a selectively greater recognition of fear relative to the subjects with no history of depression. The abnormal fear processing observed in the subjects with a previous history of depression was normalized following citalopram infusion, an effect that was opposite to that seen with the subjects with no history of depression.
CONCLUSIONS: These results suggest that increased recognition of fear is a trait vulnerability marker for depression and that this is normalized following a single dose of citalopram.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14702268     DOI: 10.1176/appi.ajp.161.1.166

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  40 in total

1.  Prefrontal cortical response to emotional faces in individuals with major depressive disorder in remission.

Authors:  Rebecca Kerestes; Zubin Bhagwagar; Pradeep J Nathan; Shashwath A Meda; Cecile D Ladouceur; Kathleen Maloney; David Matuskey; Barbara Ruf; Aybala Saricicek; Fei Wang; Godfrey D Pearlson; Mary L Phillips; Hilary P Blumberg
Journal:  Psychiatry Res       Date:  2012-05-16       Impact factor: 3.222

2.  Monoallelic expression of MAO-A in skin fibroblasts.

Authors:  N Nordquist; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  2007-04-04       Impact factor: 3.575

Review 3.  Deficits in facial affect recognition among antisocial populations: a meta-analysis.

Authors:  Abigail A Marsh; R J R Blair
Journal:  Neurosci Biobehav Rev       Date:  2007-09-01       Impact factor: 8.989

4.  Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders.

Authors:  Howard O'Rourke; Julie L Fudge
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

5.  A two-factor model of relapse/recurrence vulnerability in unipolar depression.

Authors:  Norman A S Farb; Julie A Irving; Adam K Anderson; Zindel V Segal
Journal:  J Abnorm Psychol       Date:  2015-02

Review 6.  Affective cognition and its disruption in mood disorders.

Authors:  Rebecca Elliott; Roland Zahn; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

Review 7.  Differences in how macaques monitor others: Does serotonin play a central role?

Authors:  Hannah Weinberg-Wolf; Steve W C Chang
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2019-02-18

8.  Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Gitte M Knudsen; Julian Macoveanu; Allan R Hansen; Olaf B Paulson; Hartwig R Siebner; Lars V Kessing
Journal:  Trials       Date:  2010-10-13       Impact factor: 2.279

Review 9.  'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.

Authors:  Catherine J Harmer; Philip J Cowen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

10.  Effect of a single dose of citalopram on amygdala response to emotional faces.

Authors:  Susannah E Murphy; Raymond Norbury; Ursula O'Sullivan; Philip J Cowen; Catherine J Harmer
Journal:  Br J Psychiatry       Date:  2009-06       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.